---
title: "10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292512508.md"
description: "Analysts have raised the average 12-month price target for 10x Genomics, Inc. to $35.46, up from previous estimates, though this implies a 17-22% downside from the July 10 closing price. The consensus rating remains 'Buy' among 16 covering analysts, with forecasts ranging from $20 to $46 per share."
datetime: "2026-07-13T16:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292512508.md)
  - [en](https://longbridge.com/en/news/292512508.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292512508.md)
generator: "portal-rs"
---

# 10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% Downside

-   According to estimates from 13 analysts, 10x Genomics, Inc. stock's average price target has risen from $32.08 to $33.31, with forecasts ranging from $20 to $46 per share
-   Based on the Jul. 10 closing price, the updated target implies approximately 22% potential downside
-   Consensus rating remains at “Buy” across 16 covering analysts, with 6 Buys, 9 Holds and 1 Sells

Explore more price target data and ratings for 10x Genomics, Inc. on the , and track all previous and future analyst recommendations for 10x Genomics, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TXG.US](https://longbridge.com/en/quote/TXG.US.md)

## Related News & Research

- [10x Genomics $TXG Shares Acquired by Sei Investments Co.](https://longbridge.com/en/news/295765945.md)
- [10x Genomics director Sarah A. Teichmann disposes of USD 433,106 in common shares](https://longbridge.com/en/news/296141275.md)
- [Starfighters Space, Inc. GAAP EPS of -$0.24](https://longbridge.com/en/news/296400745.md)
- [Cloudastructure Inc. reports Q2 results](https://longbridge.com/en/news/296127291.md)
- [10x Genomics director John R. Stuelpnagel sells 20,000 shares worth $1.15 million](https://longbridge.com/en/news/295839755.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**